Chanhih, N.; Laraqui, A.; Hassine, S.; Ameur, A.; Hamedoun, L.; El Annaz, H.; Abi, R.; Tagajdid, M.R.; Amine, I.L.; Ennibi, K.;
et al. Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. Int. J. Mol. Sci. 2025, 26, 11049.
https://doi.org/10.3390/ijms262211049
AMA Style
Chanhih N, Laraqui A, Hassine S, Ameur A, Hamedoun L, El Annaz H, Abi R, Tagajdid MR, Amine IL, Ennibi K,
et al. Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. International Journal of Molecular Sciences. 2025; 26(22):11049.
https://doi.org/10.3390/ijms262211049
Chicago/Turabian Style
Chanhih, Nouhaila, Abdelilah Laraqui, Salma Hassine, Ahmed Ameur, Larbi Hamedoun, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Idriss Lahlou Amine, Khalid Ennibi,
and et al. 2025. "Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review" International Journal of Molecular Sciences 26, no. 22: 11049.
https://doi.org/10.3390/ijms262211049
APA Style
Chanhih, N., Laraqui, A., Hassine, S., Ameur, A., Hamedoun, L., El Annaz, H., Abi, R., Tagajdid, M. R., Amine, I. L., Ennibi, K., Benjouad, A., & Belayachi, L.
(2025). Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. International Journal of Molecular Sciences, 26(22), 11049.
https://doi.org/10.3390/ijms262211049
